Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $PFE vs $RPRX | Chartloom

Compare

$PFE vs $RPRX

Pfizer Inc · Royalty Pharma PLC

PFE

Pfizer Inc

RPRX

Royalty Pharma PLC

Compare $PFE vs $RPRX

Comparing Pfizer Inc and Royalty Pharma PLC

PFEPfizer Inc

RPRXRoyalty Pharma PLC

PFEPfizer Inc

Market cap

$161.69B

P/E (TTM)

37.32x

Forward P/E (NTM)

10.22x

Forward P/S (NTM)

2.63x

Rev growth (TTM)

-0.2%

YTD performance

12.7%

52W performance

14.5%

FCF yield

6.8%

RPRXRoyalty Pharma PLC

Market cap

$32.57B

P/E (TTM)

38.65x

Forward P/E (NTM)

11.88x

Forward P/S (NTM)

9.72x

Rev growth (TTM)

10.0%

YTD performance

45.6%

52W performance

57.1%

FCF yield

1.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PFE

RPRX

Detailed metrics comparison

PFE

Pfizer Inc

RPRX

Royalty Pharma PLC

Market Cap

PFE$161.69B

RPRX$32.57B

Enterprise Value

PFE$223.91B

RPRX$40.72B

Price

PFE$28.37

RPRX$56.57

P/E Ratio

PFE37.32x

RPRX38.65x

P/S Ratio

PFE2.54x

RPRX12.84x

EV/Sales

PFE3.52x

RPRX16.06x

EV/EBITDA

PFE7.96x

RPRX25.19x

P/B Ratio

PFE1.89x

RPRX4.79x

P/FCF Ratio

PFE14.72x

RPRX56.41x

EV/FCF

PFE20.38x

RPRX70.52x

PEG Ratio

PFEN/A

RPRX3.89x

Forward P/E (NTM)

PFE10.22x

RPRX11.88x

Forward P/S (NTM)

PFE2.63x

RPRX9.72x

Revenue (TTM)

PFE$63.70B

RPRX$2.54B

Revenue Growth (YoY)

PFE-0.2%

RPRX10.0%

Forward Rev Growth

PFE-3.8%

RPRX5.2%

Gross Margin (TTM)

PFE74.7%

RPRX0.0%

Operating Margin (TTM)

PFE6.8%

RPRX59.6%

EBITDA Margin (TTM)

PFE41.7%

RPRX62.3%

Net Margin (TTM)

PFE6.8%

RPRX32.1%

FCF Margin (TTM)

PFE17.2%

RPRX22.8%

Net Income (TTM)

PFE$4.33B

RPRX$815M

FCF (TTM)

PFE$10.99B

RPRX$578M

EPS (TTM)

PFE$0.76

RPRX$1.46

ROE (TTM)

PFE4.9%

RPRX12.3%

ROA (TTM)

PFE2.1%

RPRX4.2%

ROIC (TTM)

PFE2.9%

RPRX5.2%

Cash

PFE$976M

RPRX$812M

Debt

PFE$63.19B

RPRX$8.96B

Net Cash/Debt

PFE$-62.22B

RPRX$-8.15B

Current Ratio (TTM)

PFE1.27x

RPRX2.80x

Quick Ratio (TTM)

PFE0.96x

RPRX2.80x

Debt/Equity (TTM)

PFE0.74x

RPRX1.31x

Debt/Assets (TTM)

PFE0.0%

RPRX0.0%

Interest Coverage (TTM)

PFEN/A

RPRXN/A

Net Debt/EBITDA (TTM)

PFE0.00x

RPRX0.00x

Beta

PFE0.31

RPRX0.39

52W Performance

PFE14.5%

RPRX57.1%

YTD Performance

PFE12.7%

RPRX45.6%

% from 52W High

PFE-2.9%

RPRX-12.1%

% from 52W Low

PFE20.1%

RPRX60.6%

Asset Turnover (TTM)

PFE0.31x

RPRX0.13x

FCF Yield (TTM)

PFE6.8%

RPRX1.8%

Earnings Yield (TTM)

PFE2.7%

RPRX2.5%

Dividend Yield (TTM)

PFE6.1%

RPRX1.2%

Rule of 40

PFE17.0

RPRX32.8

EV/GP/RG

PFEN/A

RPRXN/A

Ticker research

View PFE research View RPRX research

Metric	PFE Pfizer Inc	RPRX Royalty Pharma PLC
Market & Valuation
Market Cap	$161.69B	$32.57B
Enterprise Value	$223.91B	$40.72B
Price	$28.37	$56.57
P/E Ratio	37.32x	38.65x
P/S Ratio	2.54x	12.84x
EV/Sales	3.52x	16.06x
EV/EBITDA	7.96x	25.19x
P/B Ratio	1.89x	4.79x
P/FCF Ratio	14.72x	56.41x
EV/FCF	20.38x	70.52x
PEG Ratio	N/A	3.89x
Forward P/E (NTM)	10.22x	11.88x
Forward P/S (NTM)	2.63x	9.72x
Revenue & Growth
Revenue (TTM)	$63.70B	$2.54B
Revenue Growth (YoY)	-0.2%	10.0%
Forward Rev Growth	-3.8%	5.2%
Profitability
Gross Margin (TTM)	74.7%	0.0%
Operating Margin (TTM)	6.8%	59.6%
EBITDA Margin (TTM)	41.7%	62.3%
Net Margin (TTM)	6.8%	32.1%
FCF Margin (TTM)	17.2%	22.8%
Net Income (TTM)	$4.33B	$815M
FCF (TTM)	$10.99B	$578M
EPS (TTM)	$0.76	$1.46
ROE (TTM)	4.9%	12.3%
ROA (TTM)	2.1%	4.2%
ROIC (TTM)	2.9%	5.2%
Financial Health
Cash	$976M	$812M
Debt	$63.19B	$8.96B
Net Cash/Debt	$-62.22B	$-8.15B
Current Ratio (TTM)	1.27x	2.80x
Quick Ratio (TTM)	0.96x	2.80x
Debt/Equity (TTM)	0.74x	1.31x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.31	0.39
52W Performance	14.5%	57.1%
YTD Performance	12.7%	45.6%
% from 52W High	-2.9%	-12.1%
% from 52W Low	20.1%	60.6%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.13x
FCF Yield (TTM)	6.8%	1.8%
Earnings Yield (TTM)	2.7%	2.5%
Dividend Yield (TTM)	6.1%	1.2%
Other
Rule of 40	17.0	32.8
EV/GP/RG	N/A	N/A
Ticker research	View PFE research	View RPRX research

Valuation

P/E Ratio

PFE

37.32x

RPRX

38.65x

P/S Ratio

PFE

2.54x

RPRX

12.84x

EV/FCF

PFE

20.38x

RPRX

70.52x

Growth & revenue

Revenue Growth TTM

RPRX

10.0%

PFE

-0.2%

Forward Revenue Growth

RPRX

5.2%

PFE

-3.8%

Profitability & performance

Gross Margin

PFE

74.7%

RPRX

0.0%

ROE

RPRX

12.3%

PFE

4.9%

FCF Yield %

PFE

6.8%

RPRX

1.8%

52-Week Performance

RPRX

57.1%

PFE

14.5%

Detailed metrics comparison

PFE

Pfizer Inc

RPRX

Royalty Pharma PLC

Market Cap

PFE$161.69B

RPRX$32.57B

Enterprise Value

PFE$223.91B

RPRX$40.72B

Price

PFE$28.37

RPRX$56.57

P/E Ratio

PFE37.32x

RPRX38.65x

P/S Ratio

PFE2.54x

RPRX12.84x

EV/Sales

PFE3.52x

RPRX16.06x

EV/EBITDA

PFE7.96x

RPRX25.19x

P/B Ratio

PFE1.89x

RPRX4.79x

P/FCF Ratio

PFE14.72x

RPRX56.41x

EV/FCF

PFE20.38x

RPRX70.52x

PEG Ratio

PFEN/A

RPRX3.89x

Forward P/E (NTM)

PFE10.22x

RPRX11.88x

Forward P/S (NTM)

PFE2.63x

RPRX9.72x

Revenue (TTM)

PFE$63.70B

RPRX$2.54B

Revenue Growth (YoY)

PFE-0.2%

RPRX10.0%

Forward Rev Growth

PFE-3.8%

RPRX5.2%

Gross Margin (TTM)

PFE74.7%

RPRX0.0%

Operating Margin (TTM)

PFE6.8%

RPRX59.6%

EBITDA Margin (TTM)

PFE41.7%

RPRX62.3%

Net Margin (TTM)

PFE6.8%

RPRX32.1%

FCF Margin (TTM)

PFE17.2%

RPRX22.8%

Net Income (TTM)

PFE$4.33B

RPRX$815M

FCF (TTM)

PFE$10.99B

RPRX$578M

EPS (TTM)

PFE$0.76

RPRX$1.46

ROE (TTM)

PFE4.9%

RPRX12.3%

ROA (TTM)

PFE2.1%

RPRX4.2%

ROIC (TTM)

PFE2.9%

RPRX5.2%

Cash

PFE$976M

RPRX$812M

Debt

PFE$63.19B

RPRX$8.96B

Net Cash/Debt

PFE$-62.22B

RPRX$-8.15B

Current Ratio (TTM)

PFE1.27x

RPRX2.80x

Quick Ratio (TTM)

PFE0.96x

RPRX2.80x

Debt/Equity (TTM)

PFE0.74x

RPRX1.31x

Debt/Assets (TTM)

PFE0.0%

RPRX0.0%

Interest Coverage (TTM)

PFEN/A

RPRXN/A

Net Debt/EBITDA (TTM)

PFE0.00x

RPRX0.00x

Beta

PFE0.31

RPRX0.39

52W Performance

PFE14.5%

RPRX57.1%

YTD Performance

PFE12.7%

RPRX45.6%

% from 52W High

PFE-2.9%

RPRX-12.1%

% from 52W Low

PFE20.1%

RPRX60.6%

Asset Turnover (TTM)

PFE0.31x

RPRX0.13x

FCF Yield (TTM)

PFE6.8%

RPRX1.8%

Earnings Yield (TTM)

PFE2.7%

RPRX2.5%

Dividend Yield (TTM)

PFE6.1%

RPRX1.2%

Rule of 40

PFE17.0

RPRX32.8

EV/GP/RG

PFEN/A

RPRXN/A

Ticker research

View PFE research View RPRX research

Metric	PFE Pfizer Inc	RPRX Royalty Pharma PLC
Market & Valuation
Market Cap	$161.69B	$32.57B
Enterprise Value	$223.91B	$40.72B
Price	$28.37	$56.57
P/E Ratio	37.32x	38.65x
P/S Ratio	2.54x	12.84x
EV/Sales	3.52x	16.06x
EV/EBITDA	7.96x	25.19x
P/B Ratio	1.89x	4.79x
P/FCF Ratio	14.72x	56.41x
EV/FCF	20.38x	70.52x
PEG Ratio	N/A	3.89x
Forward P/E (NTM)	10.22x	11.88x
Forward P/S (NTM)	2.63x	9.72x
Revenue & Growth
Revenue (TTM)	$63.70B	$2.54B
Revenue Growth (YoY)	-0.2%	10.0%
Forward Rev Growth	-3.8%	5.2%
Profitability
Gross Margin (TTM)	74.7%	0.0%
Operating Margin (TTM)	6.8%	59.6%
EBITDA Margin (TTM)	41.7%	62.3%
Net Margin (TTM)	6.8%	32.1%
FCF Margin (TTM)	17.2%	22.8%
Net Income (TTM)	$4.33B	$815M
FCF (TTM)	$10.99B	$578M
EPS (TTM)	$0.76	$1.46
ROE (TTM)	4.9%	12.3%
ROA (TTM)	2.1%	4.2%
ROIC (TTM)	2.9%	5.2%
Financial Health
Cash	$976M	$812M
Debt	$63.19B	$8.96B
Net Cash/Debt	$-62.22B	$-8.15B
Current Ratio (TTM)	1.27x	2.80x
Quick Ratio (TTM)	0.96x	2.80x
Debt/Equity (TTM)	0.74x	1.31x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.31	0.39
52W Performance	14.5%	57.1%
YTD Performance	12.7%	45.6%
% from 52W High	-2.9%	-12.1%
% from 52W Low	20.1%	60.6%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.13x
FCF Yield (TTM)	6.8%	1.8%
Earnings Yield (TTM)	2.7%	2.5%
Dividend Yield (TTM)	6.1%	1.2%
Other
Rule of 40	17.0	32.8
EV/GP/RG	N/A	N/A
Ticker research	View PFE research	View RPRX research